
|Articles|July 21, 2003
Advisory committee to FDA: Make ipecac Rx
FDA advisory committee reevaluates OTC status of ipecac syrup, an OTC since 1965.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
5







































